News

Cognistat to introduce the newest additions “Cognistat Active Form & MCI Index” and “Cognistat Five” at the Annual Conference of the American Psychological Association in Denver, Colorado August 4-7, 2016.

 

The American Psychological Association is the largest scientific and professional organization representing psychology in the United States. APA is the world’s largest association of psychologists, with 150,000 researchers, educators, clinicians, consultants and students as its members.

 

·         APA seeks to advance psychology as a science, a profession and as a means of promoting health, education and human welfare by:

·         Encouraging the development and application of psychology in the broadest manner

·         Promoting research in psychology, the improvement of research methods and conditions and the application of research findings

·         Improving the qualifications and usefulness of psychologists by establishing high standards of ethics, conduct, education and achievement

·         Increasing and disseminating psychological knowledge through meetings, professional contacts, reports, papers, discussions and publications 

 


Cognistat Recognized by Hon. Dr. Eric Hoskins, Minister of Health & Long Term Care, Ontario Canada at Arab Health 2016

Cognistat  has been recognized as the Global Leader in computerized rapid assessment tools for the diagnosis of Alzheimer’s and dementia by Dr. Eric Hoskins, Minister of Health and Long Term Care, Ontario, Canada.

Arab Health was Novatek’s first stopping point of 2016!   The Middle East is very important to Novatek with many client installations in and around the region.  Together with Cognistat, Novatek’s medical data systems company, we were proud to be exhibiting among the many other great exhibitors at the Canada Pavilion.  Arab Health provides the largest gathering of healthcare experts in the Middle East, maybe even the world and it is the perfect fit for Novatek and Cognistat to share our innovative technologies and most importantly learn from others about what is happening in the Gulf region and the latest in healthcare and how we as an organization might gain from it.  Establishing and building our relationships face to face at events like Arab Health is what Novatek strives for to ensure quality, compliance and support to our customers in this region. This year Novatek celebrates its 20th anniversary year and we look forward to traveling to all parts of the world meeting all kinds leaders from the healthcare industry representing Canada as one of their leaders in Software & Innovation in the healthcare and pharmaceutical industries!


Cognistat Supports the National Academy of Neuropsychology (NAN)

Cognistat is pleased to again support the NAN student program by donating Cognistat Assessment System tests for raffle at the 2014 National Academy of Neuropsychology (NAN) conference in Fajarto, Puerto Rico.  This year Cognistat supported the NAN raffle by providing two $500 prizes.  The raffle proceeds benefit NAN’s student programs.

Congratulations to this year’s winners; Dr. Phillip Lett and Dr. Karen J. Haskett.  Each winner received a state-of-the-art Cognitive Assessment Tool allowing them to test and evaluate patients with cognitive impairment.


About Cognistat:

Cognistat is a rapid screening tool used to identify people suffering from mild, moderate and severe cognitive impairment.  An ever-increasing number of middle-aged and elderly people with Mild Cognitive Impairment (MCI) or the onset of dementia remains undiagnosed due to a lack of simple and effective tools. With time, mild cognitive impairment that is left untreated becomes full-blown dementia.

Cognistat is a rapid cognitive-assessment tool used to screen and quantify neuropsychological problems across a broad spectrum of patients. Cognistat quickly assesses five major domains of cognitive functioning: orientation, attention, language, spatial skills; i.e. construction, memory, calculation and reasoning.


About NAN:

The National Academy of Neuropsychology is a non-profit professional membership association for experts in the assessment and treatment of brain injuries and disorders. NAN members work in the most prestigious universities, hospitals and private practices throughout the world and are at the forefront of cutting-edge research and rehabilitation in the field of brain behavior relationships.
 


Cognistat and the Sports Concussion Institute Announce Joint Venture - Cognistat Sport

April 22nd 2014

Cognistat and the Sports Concussion Institute and pleased to announce the formation of Cognistat Sport Joint Venture Inc., whose mission is to develop science-based software tools for the evaluation of concussion and associated injuries. Both companies are committed to providing new best-in-class tools for clinicans to triage, evaluate and manage concussion in athletes. 

The Sports Concussion Institute (SCI) is a leading US provider of concussion assessment, diagnostic and clinical management services.  SCI was founded in 2005 to provide state-of-the-art assessment, treatment and prevention services for athletes and other active persons of all ages playing high velocity sports.  SCI provides specializied neurological and neurophysiological care to people with closed head injuries, acute and chronic pain, balance, memory and learning disorders.  SCI has conducted more than 100,000 assessments of neurophysiological and vestibular functioning in athletes and continues to provide concussion eduction, prevention and clinical management services to middle schools, high school, universities and professional teams through the US.

Cognistat is a market leader in evaluating cognitive function in teenagers and adults. Its state-of-the-art computerized tools are available in 13 languages and are used worldwide. The original Cognistat Paper Test was introduced in 1979 and has become the most widely used screening tool by North American neuropsychologists and other healthcare practitioners. The cloud based Cognistat Assessment System and stand-alone Cognistat Active Form are computer assisted, clinician admistered versions of the orignal paper test and are designed to interface with electronic medical records, facilitate the monitoring of patients on repeat testing and provide a paper free environment.  Cognistat Five is a five minute computer assisted test for evaluating the risk of dementia, delirium and mild congitive impairment in adults. 

Dr. Tony Strickland, president of the new joint venture said, "SCI is honored, together with Cognistat, to launch this innovative partnership that will significantly enhance the health and safety of althletes playing high velocity sports.  Additionaly, we are concerned about a subgroup of stand-alone, untried and/or untested software solutions used to evaluate concussion in althletes and to make "return to competition" decisions.  We strongly believe that clincians must play a key role in concussion evaluation and our goal is to design best-in-class software-based tools that facilitate their specialized work. Our two companies are well suited to bring a new level of excellence, combined with pragmatism and convenience, to concussion evaluation."

We invite you to visit us at Booth 1 at the 8th Annual National Summit on Sports Concussion, May 2nd, 2014 at the LAX Marriott, Los Angeles.

For further information please contact:

Jay Paik, MPH, JD, Vice President of Business Operations and General Counsel.

E-mail jay.paik@concussiontreatment.com          Phone +1 (310) 643 9595


 

Cognistat Announces New Five Minute Test for Dementia

July 29th 2013

Cognistat is pleased to announce the introduction of a new five minute test for risk assessment of Mild Cognitive Impairment (MCI) and dementia at the upcoming American Psychological Association Meeting, July 31st to August 4th, in Honolulu.  Cognistat Five© is a cognitive screening tool for use by clinicians in determining the risk for cognitive decline in adults.  The test incorporates a sophisticated clinical-based algorithm, the MCI Index, which is a graded seven point measure of cognitive decline.  The MCI Index provides clinically useful cognitive information to physicians in the diagnosis of Mild Cognitive Impairment and dementia.

Cognistat Five© is the fifth product in Cognistat’s catalogue of cognitive assessment tools.  The original Cognistat Paper test was introduced in 1979 and has become the most widely used screening tool used by North American neuropsychologists.  It is available in eleven languages and is used worldwide.  The Cognistat Assessment System and Cognistat Active Form are computer-assisted, clinician-administered versions of the original Paper test and are designed to interface with electronic medical records, facilitate the monitoring of patients on repeat testing and provide a paper-free environment.

Jonathan Mueller M.D., Chief Medical Officer, and one of the original developers of Cognistat, said, “Cognistat Five© offers primary care providers a rapid and cost effective way to screen for dementia and MCI by focusing on memory, constructions and orientation - the three ability areas most vulnerable to cognitive decline.  This enables the test to be completed in normal healthy subjects in five minutes.”  Parsa Famili, President and CEO of Cognistat said, ”Our goal is to provide cost-effective rapid computer-assisted screening tools for healthcare professionals.  We have a substantial customer base and foresee a growing need for these products in aging populations throughout the world.”

Cognistat Inc. is a privately held company based in San Francisco and Montreal with sales offices in North and South America, Europe and Asia.

Please come and visit us at booth 602 at the American Psychological Association Meeting in Honolulu.

For further information please contact:

Mr. Parsa Famili, Cognistat Inc., +1 (514) 941 8893

info@cognistat.com

www.cognistat.com


Cognistat Announces MCI Index© Screening Tool for Dementia

May 28, 2013

Cognistat is pleased to announce the introduction of a new screening tool for risk assessment of Mild Cognitive Impairment (MCI) and Dementia.  The Cognistat MCI Index© is a rapid cognitive screening tool for use by clinicians in determining the risk for cognitive decline in adults.  The MCI Index is the first cognitive assessment instrument to incorporate a sophisticated clinical-based algorithm based on a patient’s performance on tests for Memory and Constructions and incorporating adjustments for age and education.  The index provides a risk assessment that enables physicians to better diagnose Mild Cognitive Impairment in its earliest stages.

The Cognistat MCI Index is the fourth product in Cognistat’s catalogue of cognitive assessment tools.  The original Cognistat Paper test was introduced in 1977 and has become the most widely used screening tool used by North American neuropsychologists.  It is available in eleven languages and is used worldwide.  The Cognistat Assessment System and Cognistat Active Form are computer-assisted versions of the original Paper test and are designed to interface with electronic medical records, facilitate the monitoring of patients on repeat testing and provide a paper-free environment.  Both the Assessment System and the Active Form will now incorporate the MCI Index in their reports.

   Dr. Ralph Kiernan, Chief Scientific Officer, and one of the original developers of Cognistat said, “We are pleased to be able to bring this product before the clinical community and research world.  It offers the advantage of a sophisticated computer-based algorithm yet preserves the clinician-patient relationship.”  Mr. Parsa Famili, President and CEO of Cognistat said “Our goal is to provide cost-effective rapid computer-assisted screening tools for healthcare professionals.  We have a substantial customer base and foresee a growing need for these products in aging populations throughout the world.”

Cognistat Inc. is a privately held company based in San Francisco and Montreal with sales offices in North and South America, Europe and Asia. 

For further information please contact:

Mr. Parsa Famili, Cognistat Inc., +1 (514) 941 8893

pfamili@ntint.com

www.cognistat.com